Scorpion snags a Sanofi vet to lead the way to the clinic; All eyes on eli-cel as bluebird seeks a finance leader — again

Michael Streit

Upon taking the helm at precision oncology-focused Scorpion Therapeutics last summer, Axel Hoos told Endpoints News that he had a clear vision of the type of leaders he wanted to hire.

It appears that former Sanofi project head Michael Streit, one of...

Click to view original post